Wells Fargo’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $191K | Buy |
79,237
+25,388
| +47% | +$61.2K | ﹤0.01% | 4412 |
|
|
2025
Q1 | $119K | Buy |
53,849
+1,164
| +2% | +$2.57K | ﹤0.01% | 4564 |
|
|
2024
Q4 | $287K | Buy |
52,685
+15,001
| +40% | +$81.8K | ﹤0.01% | 4084 |
|
|
2024
Q3 | $313K | Sell |
37,684
-1,786
| -5% | -$14.8K | ﹤0.01% | 3909 |
|
|
2024
Q2 | $283K | Buy |
39,470
+31,176
| +376% | +$223K | ﹤0.01% | 3933 |
|
|
2024
Q1 | $71.9K | Sell |
8,294
-1,209
| -13% | -$10.5K | ﹤0.01% | 4705 |
|
|
2023
Q4 | $62.2K | Sell |
9,503
-20,535
| -68% | -$135K | ﹤0.01% | 4774 |
|
|
2023
Q3 | $300K | Sell |
30,038
-220
| -0.7% | -$2.2K | ﹤0.01% | 3808 |
|
|
2023
Q2 | $376K | Sell |
30,258
-2,308
| -7% | -$28.7K | ﹤0.01% | 3935 |
|
|
2023
Q1 | $456K | Buy |
32,566
+188
| +0.6% | +$2.63K | ﹤0.01% | 3666 |
|
|
2022
Q4 | $463K | Buy |
32,378
+3,925
| +14% | +$56.2K | ﹤0.01% | 3460 |
|
|
2022
Q3 | $727K | Buy |
28,453
+233
| +0.8% | +$5.95K | ﹤0.01% | 3227 |
|
|
2022
Q2 | $801K | Sell |
28,220
-34,130
| -55% | -$969K | ﹤0.01% | 3243 |
|
|
2022
Q1 | $2.2M | Sell |
62,350
-43,900
| -41% | -$1.55M | ﹤0.01% | 3030 |
|
|
2021
Q4 | $4.45M | Sell |
106,250
-220,542
| -67% | -$9.24M | ﹤0.01% | 2537 |
|
|
2021
Q3 | $16M | Buy |
326,792
+234,785
| +255% | +$11.5M | ﹤0.01% | 1773 |
|
|
2021
Q2 | $3.84M | Sell |
92,007
-5,293
| -5% | -$221K | ﹤0.01% | 2974 |
|
|
2021
Q1 | $3.47M | Buy |
97,300
+30,279
| +45% | +$1.08M | ﹤0.01% | 3036 |
|
|
2020
Q4 | $1.88M | Buy |
+67,021
| New | +$1.88M | ﹤0.01% | 3498 |
|